Why did SHLTN.SW jump after hours on 02 Jan 2026?

The after-hours rise to CHF1.18 followed heavy trading of 143,309 shares and investor interest tied to device collaborations and improved cash per share; there was no single public regulatory event reported.

What are SHL Telemedicine Ltd.'s key valuation metrics?

Key metrics at CHF1.18 include EPS -0.76, PE -1.55, price-to-sales 0.43 and price-to-book 0.63, showing a valuation discount versus Healthcare peers and reflecting negative earnings.

What is Meyka AI's rating for SHLTN.SW and what does it mean?

Meyka AI gives SHLTN.SW a score of 65.75 (Grade B) with a HOLD suggestion; this factors benchmark and sector comparisons, financial growth, key metrics and analyst signals and is for informational use only.

What price targets and forecast should investors consider?

Scenario targets: constructive CHF1.50 and conservative CHF0.90. Meyka AI's model projects CHF1.34 quarterly (implied +13.56% vs CHF1.18) and CHF1.11 yearly; forecasts are model-based, not guarantees.

CH Stocks

SHLTN.SW up 7.27% to CHF1.18 on 02 Jan 2026 after hours: high-volume top gainer

ByHuzaifa Zahoor January 2, 2026January 2, 2026

SHLTN.SW stock rose 7.27% to CHF1.18 after hours on 02 Jan 2026, driven by a 143,309-share session that outpaced the 18,897 average volume and made SHL Telemedicine Ltd. one of the top gainers on the SIX in Switzerland. The move follows a recent run above the 50-day average of CHF1.07 and comes as investors reassess product collaborations, cash position and near-term revenue visibility in the Healthcare information services industry.